Detection of β-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by Mutation-specific Restriction Enzyme Digestion (MSRED): An ancillary diagnostic tool

American Journal of Surgical Pathology

Volumn 31, Issue 9, 2007, Pages 1299-1309

  Amary, Maria Fernanda C ^a,b   Pauwels, Patrick ^e   Meulemans, Els ^f   Roemen, Guido M ^f   Islam, Lily ^b   Idowu, Bernadine ^b   Bousdras, Konstantinos ^c   Diss, Timothy C ^c   O'Donnell, Paul ^b   Flanagan, Adrienne M ^a,c,d  

^a Interdisciplinary Center for Clinical Neuromodulation   (Brazil)

^b ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f Hospital   (Netherlands)

Author keywords

catenin; Desmoid; Fibromatosis; Foot; Mutation

Indexed keywords

BETA CATENIN; PARAFFIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CODON; CONTROLLED STUDY; DESMOID TUMOR; EXON; FEMALE; FIBROMATOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; PROTEIN EXPRESSION; RESTRICTION MAPPING; SOFT TISSUE TUMOR;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; BETA CATENIN; CELL NUCLEUS; CHILD; CODON; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; FEMALE; FIBROMATOSIS, AGGRESSIVE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PARAFFIN EMBEDDING; PREDICTIVE VALUE OF TESTS; RESTRICTION MAPPING; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS;

EID: 34548206471     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31802f581a     Document Type: Article

References (52)

1. Abraham SC, Reynolds C, Lee JH, et al. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway. Hum Pathol. 2002;33:39-46.
2. Alexander IJ, Johnson KA, Shives TC, et al. Aggressive fibromatosis of the plantar aspect of the foot. A case report. Bul Hos Jt Dis Orthop Inst. 1987;47:103-108.
3. Alman BA, Li C, Pajerski ME, et al. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol. 1997;151:329-334.
4. Alman BA, Pajerski ME, az-Cano S, et al. Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol. 1997;6:98-101.
5. Barbella R, Fox IM. Recurring desmoid tumor of the foot: a case study. Foot Ankle Int. 1996;17:221-225.
6. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, et al. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol. 2005;29:653-659.
7. Breiner JA, Nelson M, Bredthauer BD, et al. Trisomy 8 and trisomy 14 in plantar fibromatosis. Cancer Genet Cytogenet. 1999;108:176-177.
8. Chan EF. Pilomatricomas contain activating mutations in beta-catenin. J Am Acad Dermatol. 2000;43:701-702.
9. Chansky HA, Trumble TE, Conrad EU, et al. Evidence for a polyclonal etiology of palmar fibromatosis. J Hand Surg. 1999;24:339-344.
10. Ferenc T, Sygut J, Kopczynski J, et al. Aggressive fibromatosis (desmoid tumors): definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background. Pol J Pathol. 2006;57:5-15.
11. Fetsch JF, Laskin WB, Miettinen M. Palmar-plantar fibromatosis in children and preadolescents: a clinicopathologic study of 56 cases with newly recognized demographics and extended follow-up information. Am J Surg Pathol. 2005;29:1095-1105.
12. Fotiadis C, Tsekouras DK, Antonakis P, et al. Gardner's syndrome: a case report and review of the literature. World J Gastroenterol. 2005;11:5408-5411.
13. Fujito T, Sasaki Y, Iwao K, et al. Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinoma. Hepatogastroenterology. 2004;51:921-924.
14. Fukuchi T, Sakamoto M, Tsuda H, et al. Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res. 1998;58:3526-3528.
15. Garcia-Rostan G, Tallini G, Herrero A, et al. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Cancer Res. 1999;59:1811-1815.
16. Giarola M, Wells D, Mondini P, et al. Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours. Br J Cancer. 1998;78:582-587.
17. Gronchi A, Casali PG, Mariani L, et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol. 2003;21:1390-1397.
18. Hauben EI, Jundt G, Cleton-Jansen AM, et al. Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin. Hum Pathol 2005;36:1025-1030.
19. Heinrich MC, McArthur GA, Demetri GD, et al. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol. 2006;24:1195-1203.
20. Henderson SR, Guiliano D, Presneau N, et al. A molecular map of mesenchymal tumors. Genome Biol. 2005;6:R76.1-R76.11.
21. Idowu BD, Al-Adnani M, O'Donnell P, et al. A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone. Histopathology. 2006. In press.
22. Kitazawa S, Kitazawa R, Obayashi C, et al. Desmoid tumor with ossification in chest wall: possible involvement of BAMBI promoter hypermethylation in metaplastic bone formation. J Bone Miner Res. 2005;20:1472-1477.
23. Koch A, Denkhaus D, Albrecht S, et al. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res. 1999;59:269-273.
24. Levy AD, Hobbs CM. From the archives of the AFIP. Meckel diverticulum: radiologic features with pathologic Correlation. Radiographics. 2004;24:565-587.
25. Li C, Bapat B, Alman BA. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol. 1998;153:709-714.
26. Luchtenborg M, Weijenberg MP, Roemen GM, et al. APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study. Carcinogenesis. 2004;25:1219-1226.
27. Mendenhall WM, Zlotecki RA, Morris CG, et al. Aggressive fibromatosis. Am J Clin Oncol. 2005;28:211-215.
28. Miyoshi Y, Iwao K, Nagasawa Y, et al. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res. 1998;58:2524-2527.
29. Miyoshi Y, Iwao K, Nawa G, et al. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res. 1998;10:591-594.
30. Montgomery E, Folpe AL. The diagnostic value of beta-catenin immunohistochemistry. Adv Anat Pathol. 2005;12:350-356.
31. Montgomery E, Lee JH, Abraham SC, et al. Superficial fibromatoses are genetically distinct from deep fibromatoses. Mod Pathol. 2001;14:695-701.
32. Montgomery E, Torbenson MS, Kaushal M, et al. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol. 2002;26:1296-1301.
33. Ng TL, Gown AM, Barry TS, et al. Nuclear beta-catenin in mesenchymal tumors. Mod Pathol. 2005;18:68-74.
34. Pakos EE, Tsekeris PG, Goussia AC. Desmoid tumours of the extremities and trunk: a review of the literature. Int Orthop. 2005;29:210-213.
35. Polakis P. The adenomatous polyposis coli (APC) tumor supressor. Biochim Biophys Acta. 1997;7:127-147.
36. Polakis P. Wnt signaling and cancer. Genes Dev. 2000;14:1837-1851.
37. Rakheja D, Molberg KH, Roberts CA, et al. Immunohistochemical expression of beta-catenin in solitary fibrous tumors. Arch Pathol Lab Med. 2005;129:776-779.
38. Reitamo JJ, Hayry P, Nykyri E, et al. The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol. 1982;77:665-673.
39. Robbin MR, Murphey MD, Temple HT, et al. Imaging of musculoskeletal fibromatosis. Radiographics. 2001;21:585-600.
40. Rubinfeld B, Albert I, Porfiri E, et al. Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res. 1997;57:4624-4630.
41. Saito T, Oda Y, Tanaka K, et al. beta-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours. J Pathol. 2001;195:222-228.
42. Sakamoto A, Oda Y, Adachi T, et al. Beta-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma. Arch Pathol Lab Med. 2002;126:1071-1078.
43. Scott RJ, Froggatt NJ, Trembath RC, et al. Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 30 APC gene mutation. Hum Mol Genet. 1996;5:1921-1924.
44. Shitoh K, Konishi F, Iijima T, et al. A novel case of a sporadic desmoid tumour with mutation of the beta catenin gene. J Clin Pathol. 1999;52:695-696.
45. Sparks AB, Morin PJ, Vogelstein B, et al. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res. 1998;58:1130-1134.
46. Sturt S, Gallagher MC, Bassett P, et al. Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut. 2004;53:1832-1836.
47. Tejpar S, Nollet F, Li C, et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene. 1999;18:6615-6620.
48. Varallo VM, Gan BS, Seney S, et al. Beta-catenin expression in Dupuytren's disease: potential role for cell-matrix interactions in modulating beta-catenin levels in vivo and in vitro. Oncogene. 2003;22:3680-3684.
49. Voeller HJ, Truica CI, Gelmann EP. Beta-catenin mutations in human prostate cancer. Cancer Res. 1998;58:2520-2523.
50. Wang L, Zhu H. Clonal analysis of palmar fibromatosis: a study whether palmar fibromatosis is a real tumor. J Transl Med. 2006;4:21-28.
51. Weiss SW, Goldblum JR, eds. Enzinger and Weiss's Soft Tissue Tumours. 4th ed. St Louis: Mosby; 2001:309-346.
52. Williamson R, Searle J. Multinucleated giant cells in plantar fibromatosis. Am J Surg Pathol. 2002;26:1235.